Skip to main content
Robert Kim, MD, Cardiology, Jacksonville, FL

RobertJKimMD

Cardiology Jacksonville, FL

Adult Congenital Heart Disease, Cardiac Electrophysiology

Assistant Professor, Medicine, University of Florida College of Medicine

Are you Dr. Kim?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    655 W 8th St
    Ufjp Cardiology
    Jacksonville, FL 32209
    Phone+1 904-244-4198

Summary

  • Dr. Robert Kim, MD is a cardiologist in Jacksonville, Florida. He is currently licensed to practice medicine in Florida, Georgia, and Georgia. He is an Assistant Professor at University of Florida College of Medicine.

Education & Training

  • Tufts University School of Medicine
    Tufts University School of MedicineClass of 1998

Certifications & Licensure

  • NH State Medical License
    NH State Medical License 2004 - Present
  • FL State Medical License
    FL State Medical License 2008 - 2026
  • GA State Medical License
    GA State Medical License 2009 - 2026
  • GA State Medical License
    GA State Medical License 2009 - 2026
  • MA State Medical License
    MA State Medical License 1999 - 2004
  • Cardiovascular Disease
    American Board of Internal Medicine Cardiovascular Disease
  • Clinical Cardiac Electrophysiology
    American Board of Internal Medicine Clinical Cardiac Electrophysiology

Publications & Presentations

PubMed

Press Mentions

  • GSK Vet Antony Blanc Signs on to Become CureVac's CBO and CCO; Chris Cabell Out, Paul Streck in as Arena Pharmaceuticals CMO
    GSK Vet Antony Blanc Signs on to Become CureVac's CBO and CCO; Chris Cabell Out, Paul Streck in as Arena Pharmaceuticals CMODecember 4th, 2020
  • 4DMT Presents Additional Positive Interim Data from Intravitreal 4D-150 Phase 1/2 PRISM Clinical Trial in Patients with Wet AMD at ASRS 2023
    4DMT Presents Additional Positive Interim Data from Intravitreal 4D-150 Phase 1/2 PRISM Clinical Trial in Patients with Wet AMD at ASRS 2023July 30th, 2023